Clinical Trial Update: Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C Virus [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating the pharmacokinetics of daclatasvir/sofosbuvir in adolescents with chronic hepatitis C virus infection across Phase 2 and Pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daclatasvir/Sofosbuvir

Snippet

Sponsor: Ain Shams University | Conditions: Chronic HCV Infection | Phase 2, Phase 3 | Status: UNKNOWN